Celltrion Pharm (Korea) Analysis

068760 Stock  KRW 56,100  2,757  4.68%   
Celltrion Pharm is overvalued with Real Value of 47402.0 and Hype Value of 56100.0. The main objective of Celltrion Pharm stock analysis is to determine its intrinsic value, which is an estimate of what Celltrion Pharm is worth, separate from its market price. There are two main types of Celltrion Pharm's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Celltrion Pharm's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Celltrion Pharm's stock to identify patterns and trends that may indicate its future price movements.
The Celltrion Pharm stock is traded in Korea on KOSDAQ, with the market opening at 09:00:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Celltrion Pharm's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celltrion Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Celltrion Stock Analysis Notes

About 58.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Celltrion Pharm had 1:1 split on the 30th of September 2024. Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea. Celltrionph is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on Celltrion Pharm please contact Jungsu Seo at 82 4 3717 7000 or go to https://www.celltrionph.com.

Celltrion Pharm Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Celltrion Pharm's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Celltrion Pharm or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Celltrion Pharm generated a negative expected return over the last 90 days
Celltrion Pharm has high historical volatility and very poor performance
About 58.0% of the company shares are owned by insiders or employees

Celltrion Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.1 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Celltrion Pharm's market, we take the total number of its shares issued and multiply it by Celltrion Pharm's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Celltrion Profitablity

Celltrion Pharm's profitability indicators refer to fundamental financial ratios that showcase Celltrion Pharm's ability to generate income relative to its revenue or operating costs. If, let's say, Celltrion Pharm is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Celltrion Pharm's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Celltrion Pharm's profitability requires more research than a typical breakdown of Celltrion Pharm's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.11 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.11.

Technical Drivers

As of the 30th of December, Celltrion Pharm shows the Risk Adjusted Performance of (0.05), standard deviation of 3.0, and Mean Deviation of 2.14. Celltrion Pharm technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Celltrion Pharm Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Celltrion Pharm middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Celltrion Pharm. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Celltrion Pharm Outstanding Bonds

Celltrion Pharm issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Celltrion Pharm uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Celltrion bonds can be classified according to their maturity, which is the date when Celltrion Pharm has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Celltrion Pharm Predictive Daily Indicators

Celltrion Pharm intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Celltrion Pharm stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Celltrion Pharm Forecast Models

Celltrion Pharm's time-series forecasting models are one of many Celltrion Pharm's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Celltrion Pharm's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Celltrion Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Celltrion Pharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Celltrion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Celltrion Pharm. By using and applying Celltrion Stock analysis, traders can create a robust methodology for identifying Celltrion entry and exit points for their positions.
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea. Celltrionph is traded on Korean Securities Dealers Automated Quotations in South Korea.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Celltrion Pharm to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Global Correlations Now

   

Global Correlations

Find global opportunities by holding instruments from different markets
All  Next Launch Module

Complementary Tools for Celltrion Stock analysis

When running Celltrion Pharm's price analysis, check to measure Celltrion Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celltrion Pharm is operating at the current time. Most of Celltrion Pharm's value examination focuses on studying past and present price action to predict the probability of Celltrion Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celltrion Pharm's price. Additionally, you may evaluate how the addition of Celltrion Pharm to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Transaction History
View history of all your transactions and understand their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk